TY - JOUR AU - Laouri, M. AU - Chen, E. AU - Looman, M. AU - Gallagher, M. PY - 2011 DA - 2011// TI - The burden of disease of retinal vein occlusion: review of the literature JO - Eye (Lond) VL - 25 UR - https://doi.org/10.1038/eye.2011.92 DO - 10.1038/eye.2011.92 ID - Laouri2011 ER - TY - JOUR AU - Wong, T. Y. AU - Scott, I. U. PY - 2010 DA - 2010// TI - Clinical practice Retinal-vein occlusion JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMcp1003934 DO - 10.1056/NEJMcp1003934 ID - Wong2010 ER - TY - JOUR AU - Vinores, S. A. AU - Derevjanik, N. L. AU - Ozaki, H. AU - Okamoto, N. AU - Campochiaro, P. A. PY - 1999 DA - 1999// TI - Cellular mechanisms of blood-retinal barrier dysfunction in macular edema JO - Doc Ophthalmol VL - 97 UR - https://doi.org/10.1023/A:1002136712070 DO - 10.1023/A:1002136712070 ID - Vinores1999 ER - TY - JOUR AU - Aiello, L. P. AU - Avery, R. L. AU - Arrigg, P. G. AU - Keyt, B. A. AU - Jampel, H. D. AU - Shah, S. T. PY - 1994 DA - 1994// TI - Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders JO - N Engl J Med VL - 331 UR - https://doi.org/10.1056/NEJM199412013312203 DO - 10.1056/NEJM199412013312203 ID - Aiello1994 ER - TY - JOUR AU - Boyd, S. R. AU - Zachary, I. AU - Chakravarthy, U. AU - Allen, G. J. AU - Wisdom, G. B. AU - Cree, I. A. PY - 2002 DA - 2002// TI - Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion JO - Arch Ophthalmol VL - 120 UR - https://doi.org/10.1001/archopht.120.12.1644 DO - 10.1001/archopht.120.12.1644 ID - Boyd2002 ER - TY - JOUR AU - Tan, M. H. AU - McAllister, I. L. AU - Gillies, M. E. AU - Verma, N. AU - Banerjee, G. AU - Smithies, L. A. PY - 2014 DA - 2014// TI - Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion JO - Am J Ophthalmol VL - 157 UR - https://doi.org/10.1016/j.ajo.2013.08.013 DO - 10.1016/j.ajo.2013.08.013 ID - Tan2014 ER - TY - JOUR AU - Kinge, B. AU - Stordahl, P. B. AU - Forsaa, V. AU - Fossen, K. AU - Haugstad, M. AU - Helgesen, O. H. PY - 2010 DA - 2010// TI - Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study JO - Am J Ophthalmol VL - 150 UR - https://doi.org/10.1016/j.ajo.2010.03.028 DO - 10.1016/j.ajo.2010.03.028 ID - Kinge2010 ER - TY - JOUR AU - Rajendram, R. AU - Fraser-Bell, S. AU - Kaines, A. AU - Michaelides, M. AU - Hamilton, R. D. AU - Esposti, S. D. PY - 2012 DA - 2012// TI - A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3 JO - Arch Ophthalmol VL - 130 UR - https://doi.org/10.1001/archophthalmol.2012.393 DO - 10.1001/archophthalmol.2012.393 ID - Rajendram2012 ER - TY - JOUR AU - Wroblewski, J. J. AU - Wells, J. R. AU - Adamis, A. P. AU - Buggage, R. R. AU - Cunningham, E. J. AU - Goldbaum, M. PY - 2009 DA - 2009// TI - Pegaptanib sodium for macular edema secondary to central retinal vein occlusion JO - Arch Ophthalmol VL - 127 UR - https://doi.org/10.1001/archophthalmol.2009.14 DO - 10.1001/archophthalmol.2009.14 ID - Wroblewski2009 ER - TY - JOUR AU - Ferrara, N. AU - Damico, L. AU - Shams, N. AU - Lowman, H. AU - Kim, R. PY - 2006 DA - 2006// TI - Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration JO - Retina VL - 26 UR - https://doi.org/10.1097/01.iae.0000242842.14624.e7 DO - 10.1097/01.iae.0000242842.14624.e7 ID - Ferrara2006 ER - TY - JOUR AU - Heier, J. S. AU - Campochiaro, P. A. AU - Yau, L. AU - Li, Z. AU - Saroj, N. AU - Rubio, R. G. PY - 2012 DA - 2012// TI - Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial JO - Ophthalmology VL - 119 UR - https://doi.org/10.1016/j.ophtha.2011.12.005 DO - 10.1016/j.ophtha.2011.12.005 ID - Heier2012 ER - TY - JOUR AU - Campochiaro, P. A. AU - Heier, J. S. AU - Feiner, L. AU - Gray, S. AU - Saroj, N. AU - Rundle, A. C. PY - 2010 DA - 2010// TI - Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study JO - Ophthalmology VL - 117 UR - https://doi.org/10.1016/j.ophtha.2010.02.021 DO - 10.1016/j.ophtha.2010.02.021 ID - Campochiaro2010 ER - TY - JOUR AU - Brown, D. M. AU - Campochiaro, P. A. AU - Singh, R. P. AU - Li, Z. AU - Gray, S. AU - Saroj, N. PY - 2010 DA - 2010// TI - Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study JO - Ophthalmology VL - 117 UR - https://doi.org/10.1016/j.ophtha.2010.02.022 DO - 10.1016/j.ophtha.2010.02.022 ID - Brown2010 ER - TY - JOUR AU - Pielen, A. AU - Feltgen, N. AU - Isserstedt, C. AU - Callizo, J. AU - Junker, B. AU - Schmucker, C. PY - 2013 DA - 2013// TI - Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0078538 DO - 10.1371/journal.pone.0078538 ID - Pielen2013 ER - TY - JOUR AU - Glanville, J. AU - Patterson, J. AU - McCool, R. AU - Ferreira, A. AU - Gairy, K. AU - Pearce, I. PY - 2014 DA - 2014// TI - Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review JO - BMC Ophthalmol VL - 14 UR - https://doi.org/10.1186/1471-2415-14-7 DO - 10.1186/1471-2415-14-7 ID - Glanville2014 ER - TY - STD TI - Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011): Section 7.7.3.5 The Cochrane Collaboration 2008. Available at: http://www.cochrane-handbook.org/. Accessed May 05, 2008. UR - http://www.cochrane-handbook.org/ ID - ref16 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - J Clin Epidemiol VL - 62 UR - https://doi.org/10.1016/j.jclinepi.2009.06.005 DO - 10.1016/j.jclinepi.2009.06.005 ID - Moher2009 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Egger, M. AU - Davey, S. G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Begg, C. B. AU - Mazumdar, M. PY - 1994 DA - 1994// TI - Operating characteristics of a rank correlation test for publication bias JO - Biometrics VL - 50 UR - https://doi.org/10.2307/2533446 DO - 10.2307/2533446 ID - Begg1994 ER - TY - JOUR AU - Thach, A. B. AU - Yau, L. AU - Hoang, C. AU - Tuomi, L. PY - 2014 DA - 2014// TI - Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein Occlusion: BRAVO and CRUISE Trials JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2013.11.022 DO - 10.1016/j.ophtha.2013.11.022 ID - Thach2014 ER - TY - JOUR AU - Campochiaro, P. A. AU - Sophie, R. AU - Pearlman, J. AU - Brown, D. M. AU - Boyer, D. S. AU - Heier, J. S. PY - 2014 DA - 2014// TI - Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2013.08.038 DO - 10.1016/j.ophtha.2013.08.038 ID - Campochiaro2014 ER - TY - JOUR AU - Varma, R. AU - Bressler, N. M. AU - Suner, I. AU - Lee, P. AU - Dolan, C. M. AU - Ward, J. PY - 2012 DA - 2012// TI - Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials JO - Ophthalmology VL - 119 UR - https://doi.org/10.1016/j.ophtha.2012.05.017 DO - 10.1016/j.ophtha.2012.05.017 ID - Varma2012 ER - TY - JOUR AU - Campochiaro, P. A. AU - Brown, D. M. AU - Awh, C. C. AU - Lee, S. Y. AU - Gray, S. AU - Saroj, N. PY - 2011 DA - 2011// TI - Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study JO - Ophthalmology VL - 118 UR - https://doi.org/10.1016/j.ophtha.2011.02.038 DO - 10.1016/j.ophtha.2011.02.038 ID - Campochiaro2011 ER - TY - JOUR AU - Brown, D. M. AU - Campochiaro, P. A. AU - Bhisitkul, R. B. AU - Ho, A. C. AU - Gray, S. AU - Saroj, N. PY - 2011 DA - 2011// TI - Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study JO - Ophthalmology VL - 118 UR - https://doi.org/10.1016/j.ophtha.2011.02.022 DO - 10.1016/j.ophtha.2011.02.022 ID - Brown2011 ER - TY - JOUR AU - Pacella, E. AU - Pacella, F. AU - Torre, G. AU - Impallara, D. AU - Malarska, K. AU - Brillante, C. PY - 2012 DA - 2012// TI - Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment JO - Clin Ter VL - 163 ID - Pacella2012 ER - TY - JOUR AU - Figueroa, M. S. AU - Contreras, I. PY - 2012 DA - 2012// TI - Potential anti-vascular endothelial growth factor therapies for central retinal vein occlusion JO - Drugs VL - 72 UR - https://doi.org/10.2165/11640820-000000000-00000 DO - 10.2165/11640820-000000000-00000 ID - Figueroa2012 ER - TY - JOUR AU - Menke, M. N. AU - Zinkernagel, M. S. AU - Ebneter, A. AU - Wolf, S. PY - 2014 DA - 2014// TI - Functional and anatomical outcome of eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab following an exit strategy regimen JO - Br J Ophthalmol VL - 98 UR - https://doi.org/10.1136/bjophthalmol-2013-304775 DO - 10.1136/bjophthalmol-2013-304775 ID - Menke2014 ER - TY - JOUR AU - Sawada, T. AU - Kakinoki, M. AU - Wang, X. AU - Kawamura, H. AU - Saishin, Y. AU - Ohji, M. PY - 2014 DA - 2014// TI - Bimonthly injections of ranibizumab for age-related macular degeneration JO - Graefes Arch Clin Exp Ophthalmol VL - 252 UR - https://doi.org/10.1007/s00417-014-2612-8 DO - 10.1007/s00417-014-2612-8 ID - Sawada2014 ER - TY - JOUR AU - Yanagida, Y. AU - Ueta, T. PY - 2014 DA - 2014// TI - Systemic safety of ranibizumab for diabetic macular edema: meta-analysis of randomized trials JO - Retina VL - 34 UR - https://doi.org/10.1097/IAE.0000000000000116 DO - 10.1097/IAE.0000000000000116 ID - Yanagida2014 ER -